Azitra expects initial results from ATR-COSF first-in-human study by year-end

AZTR•2026-11-10

Azitra expects initial results from its first-in-human ATR-COSF study by year-end. The topical cosmetic candidate reduced visible wrinkles and improved skin elasticity in ex vivo human skin models, and Azitra will present preclinical results at BIO-Europe on November 10, 2026.

Azitra expects initial results from ATR-COSF first-in-human study by year-end

1. Study and trial updates

Related News

Titan Machinery publishes update to financial calendar

Oppenheimer raises Live Nation target price to $215 from $210

PepGen more than doubles as muscle disease drug tops expectations

Adobe expands Google partnership to integrate AI models into creative tools

Goldman Sachs raises total voting rights in ThyssenKrupp to 5.04% from 4.98%